Novel scabies mite serpins inhibit the three pathways of the human complement system.
Scabies is a parasitic infestation of the skin by the mite Sarcoptes scabiei that causes significant morbidity worldwide, in particular within socially disadvantaged populations. In order to identify mechanisms that enable the scabies mite to evade human immune defenses, we have studied molecules associated with proteolytic systems in the mite, including two novel scabies mite serine protease inhibitors (SMSs) of the serpin superfamily. Immunohistochemical studies revealed that within mite-infected human skin SMSB4 (54 kDa) and SMSB3 (47 kDa) were both localized in the mite gut and feces. Recombinant purified SMSB3 and SMSB4 did not inhibit mite serine and cysteine proteases, but did inhibit mammalian serine proteases, such as chymotrypsin, albeit inefficiently. Detailed functional analysis revealed that both serpins interfered with all three pathways of the human complement system at different stages of their activation. SMSB4 inhibited mostly the initial and progressing steps of the cascades, while SMSB3 showed the strongest effects at the C9 level in the terminal pathway. Additive effects of both serpins were shown at the C9 level in the lectin pathway. Both SMSs were able to interfere with complement factors without protease function. A range of binding assays showed direct binding between SMSB4 and seven complement proteins (C1, properdin, MBL, C4, C3, C6 and C8), while significant binding of SMSB3 occurred exclusively to complement factors without protease function (C4, C3, C8). Direct binding was observed between SMSB4 and the complement proteases C1s and C1r. However no complex formation was observed between either mite serpin and the complement serine proteases C1r, C1s, MASP-1, MASP-2 and MASP-3. No catalytic inhibition by either serpin was observed for any of these enzymes. In summary, the SMSs were acting at several levels mediating overall inhibition of the complement system and thus we propose that they may protect scabies mites from complement-mediated gut damage.
Infectious Diseases Program, Biology Department, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
Angela
A
Mika
Simone L
SL
Reynolds
Frida C
FC
Mohlin
Charlene
C
Willis
Pearl M
PM
Swe
Darren A
DA
Pickering
Vanja
V
Halilovic
Lakshmi C
LC
Wijeyewickrema
Robert N
RN
Pike
Anna M
AM
Blom
David J
DJ
Kemp
Katja
K
Fischer
D000595:Amino Acid Sequence; D000818:Animals; D060829:Arthropod Proteins / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D003167:Complement Activation / Q000187:drug effects; D003169:Complement Inactivator Proteins / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D003165:Complement System Proteins / Q000737:chemistry; D041981:Gastrointestinal Tract / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D010314:Partial Thromboplastin Time; D010447:Peptide Hydrolases / Q000737:chemistry; D011485:Protein Binding; D012520:Sarcoptes scabiei / Q000378:metabolism*; D012532:Scabies / Q000276:immunology / Q000469:parasitology; D017422:Sequence Analysis, DNA; D015842:Serine Proteinase Inhibitors / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D015843:Serpins / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology
D060829:Arthropod Proteins; D003169:Complement Inactivator Proteins; D015842:Serine Proteinase Inhibitors; D015843:Serpins; D003165:Complement System Proteins; D010447:Peptide Hydrolases